Yohimbine Hydrochloride

盐酸育宾亨

Report date: 2022/08/09 18:05:59
NME

Base Information

Drug NameYohimbine Hydrochloride
Drug Alias NameYocon
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor antagonists
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsDepressive Disorder, MajorPhobia, SocialDepression +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesWayne State University
Active IndicationsMarijuana AbuseErectile Dysfunction
Inactive IndicationsDepressive Disorder, MajorPhobia, SocialDepression +[5

Other Information

ATC CodeG04BE04